BIEI Stock Chart & Stats
<$0.01
<$0.01(5.00%)
At close: 4:00 PM EDT
<$0.01
<$0.01(5.00%)
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
Volume1.21M
Average Volume (3M)N/A
Market Cap
$974.99K
Enterprise Value$1.85M
Total Cash (Recent Filing)$400.00
Total Debt (Recent Filing)$720.19K
Price to Earnings (P/E)―
Beta0.26
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding1,299,981,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)-0.40
Price to Sales (P/S)0.00
P/FCF Ratio-5.78
Enterprise Value/Market Cap1.90
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-108.85
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BIEI FAQ
What was Premier Biomedical Inc’s price range in the past 12 months?
Currently, no data Available
What is Premier Biomedical Inc’s market cap?
Premier Biomedical Inc’s market cap is $974.99K.
When is Premier Biomedical Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Premier Biomedical Inc’s earnings last quarter?
Currently, no data Available
Is Premier Biomedical Inc overvalued?
According to Wall Street analysts Premier Biomedical Inc’s price is currently Overvalued.
Does Premier Biomedical Inc pay dividends?
Premier Biomedical Inc does not currently pay dividends.
What is Premier Biomedical Inc’s EPS estimate?
Premier Biomedical Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Premier Biomedical Inc have?
Premier Biomedical Inc has 1,299,981,000 shares outstanding.
What happened to Premier Biomedical Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Premier Biomedical Inc?
Currently, no hedge funds are holding shares in BIEI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Premier Biomedical Inc
Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer’s disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries. Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania.
Scinai Immunotherapeutics
―
Aditxt
―
PainReform
―
Dermata Therapeutics
―
CERo Therapeutics Holdings
―